Medicine
Trulicity 3 mg/0.5 mL injection
Trulicity 3 mg/0.5 mL injection is a prescription medicine containing Dulaglutide for subcutaneous use, marketed by Eli Lilly, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store TRULICITY in the refrigerator at 36°F to 46°F (2°C to 8°C). Do not…
Key facts
- Active ingredient (INN)
- Dulaglutide
- Brand
- Trulicity
- Strength
- 3 mg/0.5 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 4 syringes of 0.5 mL
- Marketing authorisation holder
- Eli Lilly
- Manufacturers
- Eli LillyA-S Medication Solutions
- Origin register
- US FDA, United States
- Storage
- Store TRULICITY in the refrigerator at 36°F to 46°F (2°C to 8°C). Do not freeze TRULICITY. If needed, each single-dose pen can be kept at room temperature, not to exceed 86°F (30°C) for a total of 14 days. Storage of TRULICITY in the original carton is recommended until time of administration.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BJ05 Dulaglutide
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 September 2020
- Identifiers
- RxCUI 1551295, 1551300, 1551304 +5DailyMed set ID 463050bd-2b1c-40f5-b3c3-0a04bb433309, 6088c732-afa1-4fee-9206-22e52baf4731, 0a4716d0-9c9c-4bc3-a8f1-6784599aae89NDC 0002-2236, 50090-5467, 50090-6571Application BLA125469
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 4 syringe in 1 carton / .5 mL in 1 syringe | 0002-2236-80 | Eli Lilly | 3 September 2020 |
| 4 syringe in 1 carton / .5 mL in 1 syringe | 50090-5467-0 | A-S Medication Solutions | 11 February 2021 |
| 4 syringe in 1 carton / .5 mL in 1 syringe | 50090-6571-0 | A-S Medication Solutions | 1 August 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dulaglutide
Clinical summary
Dulaglutide is a GLP-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. MedsAcross supplies Dulaglutide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DulaglutideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Trulicity prescribing information (Eli Lilly) · U.S. National Library of Medicine, DailyMed
- Trulicity: European public assessment report (EPAR) · European Medicines Agency
Need Trulicity 3 mg/0.5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.